Macquarie Group’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.8M Sell
39,963
-200,914
-83% -$59.7M 0.07% 216
2025
Q4
$65.8M Sell
240,877
-513,864
-68% -$140M 0.29% 64
2025
Q3
$204M Buy
754,741
+176,738
+31% +$48.1M 0.24% 67
2025
Q2
$159M Buy
578,003
+12,381
+2% +$3.37M 0.2% 100
2025
Q1
$150M Sell
565,622
-170,692
-23% -$42.1M 0.19% 131
2024
Q4
$119M Buy
736,314
+155,322
+27% +$35.7M 0.14% 196
2024
Q3
$128M Buy
580,992
+79,212
+16% +$16.4M 0.14% 206
2024
Q2
$98.6M Sell
501,780
-12,141
-2% -$2.51M 0.11% 228
2024
Q1
$111M Buy
513,921
+75,508
+17% +$15.9M 0.13% 219
2023
Q4
$92.3M Buy
438,413
+379,290
+642% +$80.9M 0.11% 265
2023
Q3
$3.73M Buy
59,123
+1,395
+2% +$277K ﹤0.01% 998
2023
Q2
$10.7M Buy
57,728
+40,544
+236% +$7.49M 0.01% 772
2023
Q1
$3.29M Sell
17,184
-338,127
-95% -$61.1M ﹤0.01% 1016
2022
Q4
$59.7M Sell
355,311
-115,000
-24% -$20M 0.07% 381
2022
Q3
$83.3M Sell
470,311
-248,155
-35% -$49M 0.1% 275
2022
Q2
$147M Sell
718,466
-277,857
-28% -$58.9M 0.17% 146
2022
Q1
$237K Sell
996,323
-58,953
-6% -$13.8M 0.18% 102
2021
Q4
$241M Buy
1,055,276
+267,958
+34% +$59M 0.2% 111
2021
Q3
$152M Sell
787,318
-14,899
-2% -$3.02M 0.13% 199
2021
Q2
$171M Buy
802,217
+792,186
+7,897% +$167M 0.14% 171
2021
Q1
$2.05M Sell
10,031
-893
-8% -$176K ﹤0.01% 1200
2020
Q4
$1.99M Sell
10,924
-52,088
-83% -$8.86M ﹤0.01% 1105
2020
Q3
$10.3M Sell
63,012
-232,653
-79% -$39.2M 0.02% 643
2020
Q2
$48.1M Sell
295,665
-505,379
-63% -$90.6M 0.08% 261
2020
Q1
$139M Buy
801,044
+238,582
+42% +$47.5M 0.28% 58
2019
Q4
$113M Buy
562,462
+72,558
+15% +$14.9M 0.16% 106
2019
Q3
$104M Sell
489,904
-23,127
-5% -$4.83M 0.17% 103
2019
Q2
$99.6M Sell
513,031
-25,186
-5% -$4.64M 0.17% 105
2019
Q1
$88.6M Sell
538,217
-37,218
-6% -$6.58M 0.15% 119
2018
Q4
$108M Sell
575,435
-67,767
-11% -$12.5M 0.21% 85
2018
Q3
$109M Sell
643,202
-41,203
-6% -$6.94M 0.18% 97
2018
Q2
$112M Sell
684,405
-35,353
-5% -$5.77M 0.19% 92
2018
Q1
$116M Sell
719,758
-26,181
-4% -$4.17M 0.21% 86
2017
Q4
$122M Buy
745,939
+664,523
+816% +$94.6M 0.22% 81
2017
Q3
$11M Buy
81,416
+73,916
+986% +$9.34M 0.02% 590
2017
Q2
$939K Sell
7,500
-3,850
-34% -$460K ﹤0.01% 1182
2017
Q1
$1.35M Buy
11,350
+2,050
+22% +$247K ﹤0.01% 1092
2016
Q4
$1.07M Buy
9,300
+1,705
+22% +$190K ﹤0.01% 1143
2016
Q3
$794K Sell
7,595
-5,631
-43% -$588K ﹤0.01% 1207
2016
Q2
$1.29M Buy
13,226
+6,431
+95% +$608K ﹤0.01% 1233
2016
Q1
$653K Sell
6,795
-23,773
-78% -$2.16M ﹤0.01% 1195
2015
Q4
$2.77M Sell
30,568
-2,977
-9% -$280K 0.01% 848
2015
Q3
$3.11M Sell
33,545
-8,100
-19% -$770K 0.01% 858
2015
Q2
$3.88M Sell
41,645
-5,550
-12% -$518K 0.01% 828
2015
Q1
$4.47M Sell
47,195
-9,025
-16% -$836K 0.01% 779
2014
Q4
$4.98M Sell
56,220
-23,014
-29% -$1.95M 0.01% 723
2014
Q3
$6.33M Sell
79,234
-1,533,827
-95% -$116M 0.01% 634
2014
Q2
$114M Sell
1,613,061
-3,371,199
-68% -$237M 0.26% 91
2014
Q1
$369M Buy
4,984,260
+171,868
+4% +$13M 0.64% 61
2013
Q4
$378M Sell
4,812,392
-18,518
-0.4% -$1.45M 0.68% 59
2013
Q3
$357M Buy
4,830,910
+125,073
+3% +$9.21M 0.7% 42
2013
Q2
$358M Buy
+4,705,837
New +$309M 0.78% 27

Other funds holding CME

Macquarie Group's CME Position: Q1 2026 in Review

Macquarie Group reduced its CME Group (CME) stake by 83% in Q1 2026, selling an estimated $59.7M and leaving 39,963 shares worth $11.8M. The position accounts for 0.07% of the portfolio, ranked #216.

Macquarie Group first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $378M in Q4 2013. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Macquarie Group held 39,963 shares of CME Group worth $11.8M as of Q1 2026.
  • Macquarie Group sold 200,914 CME Group shares in Q1 2026, an estimated $59.7M.
  • CME Group made up 0.07% of Macquarie Group's portfolio in Q1 2026, its #216 holding.
  • Macquarie Group first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
  • Macquarie Group's CME Group position peaked at $378M in Q4 2013.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Macquarie Group's 13F filing for Q1 2026, filed 15 May 2026.